Tissue 3-D printing play OxSyBio unveils £10M series A

OxSyBio Ltd. (London, U.K.) secured £10 million ($13.9 million) in a series A round led by new investor Woodford Investment Management. IP Group, which seeded the company with £1 million ($1.4 million) in 2014, and new investor Parkwalk Advisors also participated.

OxSyBio said part of the round is subject to milestones, but CEO Hadrian Green declined to disclose details...